Oorsprong van het eerstegraads netwerk van Feng Tian
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.
13
| Subsidiary | Biotechnology | 13 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Feng Tian via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMBRX INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director of Finance/CFO Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| 4D PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CANBRIDGE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| REVANCE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Wuxi Apptec, Inc.
 Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Data Processing Services | Chief Investment Officer Chief Investment Officer | |
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Investment Managers | Founder Private Equity Investor | |
| VIELA BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Undergraduate Degree Doctorate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Davidson College | College/University | Undergraduate Degree | |
| MIT Sloan School of Management | College/University | Graduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Masters Business Admin | |
Proteus Digital Health, Inc.
 Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARCELLX, INC. | Biotechnology | Director/Board Member | |
| CONTINEUM THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Hopu Investments Co. Ltd.
 Hopu Investments Co. Ltd. Financial ConglomeratesFinance Hopu Investments Co. Ltd. functions as an investment holding Caymanian company. | Financial Conglomerates | Corporate Officer/Principal | |
| LADRX CORPORATION | Biotechnology | Corporate Officer/Principal | |
| Women's Resource Center | Director/Board Member | ||
| Tsinghua University | College/University | Graduate Degree | |
| China International Capital Corp. Ltd. (Private Equity) | Financial Conglomerates | Corporate Officer/Principal | |
| ZYVERSA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Cancer Drug Development Forum | Director/Board Member | ||
Iqure Pharma, Inc.
 Iqure Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Iqure Pharma, Inc. is a biotech company that develops therapeutics for patients and physicians. The company is based in Wilmington, DE. The company was founded by Pawel Zolnierczyk, Henk de Wilde, Peter Schiemann, Anna Rzewuska. Pawel Zolnierczyk has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ymmunobio AG
 Ymmunobio AG BiotechnologyHealth Technology Ymmunobio AG is a Swiss preclinical stage oncology biotech company that develops innovative treatments for cancer patients through new classes of antibodies. The company is based in Riehen, Switzerland. The company focuses on high unmet need indications in gastro-intestinal cancers, making extensive progress in developing first-in-class or novel class of antibodies that have the potential to overcome resistance of cancer patients to current available therapies. Ymmunobio's research is based on their deep understanding of immuno-oncology and precision cancer treatments, leveraging their profound knowledge of biologics while selecting the optimal approach to developing transformative therapeutics across cancer indications. The company was founded in 2021 by Katrin Rupalla. The CEO is Peter Schiemann. | Biotechnology | Founder | |
Bristol-Myers Squibb Holdings Ltd.
 Bristol-Myers Squibb Holdings Ltd. MiscellaneousMiscellaneous Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Holdings Ltd. is a holding British company. The company is based in Uxbridge, UK. | Miscellaneous | Corporate Officer/Principal | |
| Jones International University | College/University | Masters Business Admin | |
| Philipps University of Marburg | College/University | Doctorate Degree | |
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | General Counsel | |
Inex Bio, Inc.
 Inex Bio, Inc. Financial ConglomeratesFinance Part of ImmunityBio, Inc., Inex Bio, Inc. is a South Korean company that provides investment services. The company is located in South Korea. Inex Bio was acquired by NantKwest, Inc. from Inexbio Holdings LLC on March 30, 2015 for $37.85 million. | Financial Conglomerates | Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Sales & Marketing | |
83bar, Inc.
 83bar, Inc. Internet Software/ServicesTechnology Services 83bar, Inc. is a private company that specializes in patient recruitment, engagement, and journey management. The company is based in Austin, TX. The company ensures that the right patient is delivered to the right place at the right time for clinical trials and commercialization requirements. The company was founded by Sue Hrim. The CEO is Bob Baurys. | Internet Software/Services | Corporate Officer/Principal | |
| Thunderbird School of Global Management | College/University | Graduate Degree | |
Polarityte, Inc. /Brauser/
 Polarityte, Inc. /Brauser/ Financial ConglomeratesFinance Polarityte, Inc. is a private group led by Michael Brauser. | Financial Conglomerates | Director/Board Member | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Michigan | College/University | Doctorate Degree | |
| All In Together Campaign, Inc. | Director/Board Member | ||
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal | |
USC Norris Comprehensive Cancer Center
 USC Norris Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services USC Norris Comprehensive Cancer Center provides cancer research, treatment, prevention and education services. Its research programs include molecular genetics, epigenetics and regulation, tumor microenvironment, cancer control, translational and clinical sciences. The firm offers direct patient care through both inpatient and outpatient services. The company was founded in 1973 and is headquartered in Los Angeles, CA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Doctorate Degree | |
| Syracuse University | College/University | Doctorate Degree | |
| KEYMED BIOSCIENCES INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MOLECULIN BIOTECH, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CHECKMATE PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| China Medical University | College/University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 33 |
| China | 9 |
| Verenigd Koninkrijk | 3 |
| Zwitserland | 3 |
| Kaaimaneilanden | 2 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 14 |
| Finance | 7 |
| Technology Services | 3 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 79 |
| Independent Dir/Board Member | 31 |
| Corporate Officer/Principal | 31 |
| Undergraduate Degree | 10 |
| Director of Finance/CFO | 10 |
Sterkste connecties
| Insiders | |
|---|---|
| Edward Hu | 29 |
| Paul Maier | 25 |
| Christian Nolet | 15 |
| Simon Allen | 13 |
| Sonja Nelson | 13 |
| Katrin Rupalla | 13 |
| Kate Hermans | 12 |
| Olivia Ware | 10 |
| Xiao Le | 8 |
| Joy Yan | 8 |
| Janet Loesberg | 8 |
| Xiaowei Chang | 5 |
| Janice Lu | 5 |
